An intervention trial in high-risk asbestos-exposed persons.
McLarty
J W
JW
Department of Epidemiology/Biomathematics, University of Texas Health Science Center, Tyler.
D016588:Anticarcinogenic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001194:Asbestos / Q000009:adverse effects*; D002338:Carotenoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002985:Clinical Protocols; D015331:Cohort Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000209:etiology / Q000517:prevention & control*; D010349:Patient Compliance; D013183:Sputum / Q000166:cytology; D014481:United States / Q000453:epidemiology; D014801:Vitamin A / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019207:beta Carotene
D016588:Anticarcinogenic Agents; D019207:beta Carotene; D014801:Vitamin A; D001194:Asbestos; D002338:Carotenoids